Skip to content Skip to sidebar Skip to footer

News

HeraMED
HeraMED Hits Milestones with A$2 M Placement and Quarterly Report: Is the Rebound On?
HeraMED (ASX: HMD) has re-entered the spotlight with two significant announcements: a successful A$2 million placement and the release of its first half 2025 quarterly results. These developments follow a challenging trading period that included a suspension, which left many investors uncertain about the company’s future. Now, with fresh capital secured and renewed transparency in…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here